Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03986944
Recruitment Status : Terminated (Study halted due to the significant enrollment challenges encountered since its beginning. Screening and enrollment have been impacted by the COVID pandemic and more importantly by changes in the diagnosis and treatment of women with endometriosis.)
First Posted : June 14, 2019
Last Update Posted : May 12, 2021
Sponsor:
Information provided by (Responsible Party):
ObsEva SA

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 6, 2021
Actual Study Completion Date : February 16, 2021